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Abstract Bacteria associated with the marine macroalga
Laminaria saccharina, collected from the Kiel Fjord (Baltic
Sea, Germany), were isolated and tested for antimicrobial
activity. From a total of 210 isolates, 103 strains inhibited
the growth of at least one microorganism from the test
panel including Gram-negative and Gram-positive bacteria
as well as a yeast. Most common profiles were the
inhibition of Bacillus subtilis only (30%), B. subtilis and
Staphylococcus lentus (25%), and B. subtilis, S. lentus, and
Candida albicans (11%). In summary, the antibiotic-active
isolates covered 15 different activity patterns suggesting
various modes of action. On the basis of 16S rRNA gene
sequence similarities >99%, 45 phylotypes were defined,
which were classified into 21 genera belonging to Alpha-
proteobacteria, Betaproteobacteria, Gammaproteobacteria,
Bacteroidetes, Firmicutes, and Actinobacteria. Phylo-
genetic analysis of 16S rRNA gene sequences revealed
that four isolates possibly represent novel species or even
genera. In conclusion, L. saccharina represents a promising
source for the isolation of new bacterial taxa and anti-
microbially active bacteria.
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Introduction
Laminaria species provide a rich habitat for different
epiphytic, endophytic, and epizoobenthic organisms
(Bartsch et al. 2008). Epiphytic bacteria have been studied
by microscopic methods (Corre and Prieur 1990) and by
genetic and cultivation approaches. Bacterial cell numbers
of up to 107 colony-forming units (CFU) per centimeter
squared were reported for Laminaria digitata from the
coast of Brittany (France) and Laminaria pallida on the
Bengal upwelling region of southern Africa (Corre and
Prieur 1990; Mazure and Field 1980). However, the
interactions between members of the epiphytic and endo-
phytic communities and the relationships between these
communities and Laminaria spp. as well as the type of
association (specific or unspecific) are only poorly under-
stood. It is assumed that the bacterial communities in part
are specifically associated but also include opportunistic
commensal as well as algae-degrading microorganisms
(Staufenberger et al. 2008) and in consequence Laminar-
ia-associated bacteria might affect the alga positively or
negatively in different ways. Some bacteria affect the alga
in a deleterious manner by decomposing cell material, like
alginate, laminaran, or mannitol (Dimitrieva and Dimitriev
1996; Ivanova et al. 2003; Laycock 1974; Sawabe et al.
1997, 1998b, 2000) and/or by causing diseases such as
those triggered by species of Alteromonas and Pseudoalter-
omonas species and others (Wang et al. 2006; Sawabe et al.
1998a; Vairappan et al. 2001). A favorable, growth-
promoting effect of bacteria on Laminaria was shown for
Pseudoalteromonas porphyrae isolated from Laminaria
japonica in the Sea of Japan (Dimitrieva et al. 2006). This
bacterium induced improved spore germination of the alga
and extended the thallus length. An additional beneficial
effect of Laminaria-associated bacteria could be the
protection of the alga against microbial pathogens by the
production of antimicrobial substances.
Various novel compounds with antibiotic activity have
been identified from alga-associated bacteria. These chem-
ically diverse substances include new lipopeptides such as
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massetolide A, novel antibacterial lactones (macrolactines
G–M), phenazines (i.e., pelagiomycin A), and korormicin,
which exhibit a variety of activities against bacteria and
fungi pathogenic to man and plants as well as leukemic
cells (Gerard et al. 1997; Imamura et al. 1997; Yoshikawa
et al. 1997; Tran et al. 2007).
No detailed study concerning the characterization of
alga-associated bacteria exploring antibiotic effects is
available to date. In this study, we focussed on the isolation,
identification, and phylogenetic analysis of antimicrobially
active bacteria associated with the marine macroalga
Laminaria saccharina.
Materials and Methods
Sampling Site and Sampling Procedures Samples of L.
saccharina were taken from the Kiel Fjord (Baltic Sea,
Germany). The algae were collected from October 2002 to
June 2004 at approximately 6 m depth by scuba diving.
Complete algae were removed carefully from the substrate
using a knife and transferred into sterile plastic bags. All
samples were kept in the dark and at 4°C until subsequent
processing in the laboratory within 4 h of sampling.
Isolation, Cultivation, and Storage of Bacterial Strains Fresh
L. saccharina samples were cut into pieces of approximately
10 cm2, suspended in sterile sea water, and homogenized
using an Ultraturrax T25 (IKA Werke, Germany). The
suspension was diluted in sterile sea water and plated on
tryptic soy broth (TSB) medium A (3.0 g/l Difco tryptic soy
broth, 15 g/l Difco agar, 7, 10, 15, or 25 g/l NaCl,
respectively), TSB medium B (0.3 g/l Difco tryptic soy
broth, 15 g/l Difco agar, 7, 15, or 25 g/l NaCl, respectively),
or MW medium (15 g/l Difco agar in sea water), respective-
ly. Further media used were AIA-S15 (22 g/l Difco
Actinomyces isolation agar, 15 g/l NaCl), CPS-S15 modified
after Collins and Willoughby (1962; 0.5 g/l Bacto peptone,
0.5 g/l casitone, 0.5 g/l starch, 1.0 ml/L glycerine, 2.0 ml/L
10% K2HPO4 solution, 0.5 ml/L 10% MgSO4×7 H2O
solution, four drops 0.01% FeCl3 solution, 15.0 g/l agar,
15 g/l NaCl; pH 7.0), MHA-S15 (10.0 g/l malt extract,
5.0 g/l Bacto yeast extract, 15 g/l NaCl, 15.0 g/l agar; pH
6.5), MA (18.0 g/l Bacto marine broth, 15.0 g/l agar;
pH 7.6), WM-S5 modified after Wickerham (1951;
10.0 g/l glucose×H2O, 5.0 g/l Bacto peptone, 3.0 g/l Bacto
yeast extract, 3.0 g/l Bacto malt extract, 5.0 g/l NaCl,
pH 6.3), and GPY (1.0 g/l glucose×H2O, 0.5 g/l Bacto
peptone, 0.1 g/l Bacto yeast extract, 15.0 g/l NaCl,
15 g/l agar; pH 7.2). In addition, a semisynthetic polycarbon
(HSPC) medium was used (Muscholl-Silberhorn et al. 2008).
The incubation was performed in the dark at 22°C for
14 days. Pure cultures were obtained by several subsequent
isolation steps on TSB medium A (with 10 g/l NaCl). The
isolates were stored at −80°C using the Cryobank System
(Mast Diagnostica GmbH, Reinfeld, Germany) according to
the manufacturer.
Determination of the Antimicrobial Activity of the Isolates The
following test organisms were used: Escherichia coli DSM
498 as a Gram-negative strain, Staphylococcus lentus DSM
6672 and Bacillus subtilis DSM 347 as representatives of
Gram-positive bacteria, and the yeast Candida glabrata
DSM 6425, all obtained from the German Culture
Collection (DSMZ, Braunschweig, Germany).
The activity of L. saccharina-associated isolates
against the test strains was tested by using an overlay
method. The isolates were inoculated onto TSB medium A
agar plates (with 10 g/l NaCl) by streaking out cell
material on a circular area with a diameter of 1 cm. The
cultures were incubated at 22°C for 5 days before they
were covered with an overlay containing the test strains in
TSB agar C (3.0 g/l Difco tryptic soy broth, 8 g/l Difco agar,
10 g/l NaCl, pH 7.2). Overnight cultures of each test strain
with approximately 109 cells per milliliter were mixed (all
bacteria 1% v/v, C. glabrata 10% v/v) with TSB agar C,
which was then poured onto the agar surface previously
inoculated with alga-associated isolates. The plates were
incubated at 22°C for 5 days. Antibacterial activity was
defined by the formation of inhibition zones determined as
a distance of ≥1 mm between the circular area (=lawn of
the isolate) and the end of the clear zone bounded by the
lawn of the test strain.
DNA Extraction To obtain genomic DNA, cell material was
transferred from the agar plate into 500-µl DNA-free water
(Sigma-Aldrich) and homogenized (2×6,300 rpm/min for
20 s) using the Precellys24 homogenizer (PEQLAB
Biotechnologie GmbH, Erlangen, Germany). After centri-
fugation for 10 min at 8,000×g, the supernatant was
collected and the DNA extract was stored at −20°C.
16S rRNA Gene Amplification The amplification of the 16S
rRNA gene sequence was performed using puReTaq
Ready-To-Go polymerase chain reaction (PCR) Beads
(Amersham Biosciences) with the eubacterial primers 27f
and 1492r (Lane 1991). The PCR profile included the
following steps: initial denaturation (2 min at 94°C)
followed by 30 cycles of primer annealing (40 s at 50°C),
primer extension (90 s at 72°C), and denaturation (40 s at
94°C) as well as a final primer annealing (40 s at 50°C) and
extension step (5 min at 72°C).
Purification of PCR products was carried out with
Exonuclease I (Exo I, GE Healthcare) and Shrimp Alkaline
Phosphatase (SAP, Roche). For each reaction, 1.5 U of Exo
I and 0.3 U of SAP were added to the PCR product and
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incubated for 15 min at 37°C, followed by heat inactivation
of the enzymes for 15 min at 72°C. Sequencing was
performed using the BigDye Terminator v1.1 Sequencing
Kit (Applied Biosystems) in a 3730-DNA-Analyzer (Ap-
plied Biosystems) as specified by the manufacturer.
Sequencing was performed with the primers 342f (Lane
1991), 790f 5’-GATACCCTGGTAGTCC-3’, and 543r
(Muyzer et al. 1993). The 16S rRNA gene sequences were
submitted to the European Molecular Biology Laboratory
(EMBL) database with the accession nos. AM913880–
AM913982.
Phylogenetic Analysis Next relatives of the bacterial
isolates were determined by comparison to 16S rRNA
gene sequences in the NCBI GenBank and the EMBL
databases using Basic Local Alignment Search Tool
(BLAST) and the “Seqmatch” program of the Ribosomal
Database Project II (http://rdp.cme.msu.edu/seqmatch/
seqmatch_intro.jsp) restricted to type strains. Sequences
were aligned using the FastAlign function of the align-
ment editor implemented in the ARB software package
(http://www.arb-home.de; Ludwig et al. 2004) and refined
manually employing secondary structure information. For
phylogenetic calculations, the PhyML software (Guindon
and Gascuel 2003) as well as the online version of PhyML
(Guindon et al. 2005) were used. Trees were calculated by
the maximum likelihood method (Felsenstein 1981) using
the general time reversal model with the estimated
proportion of invariable sites and the Gamma distribution
parameter. Isolates with 16S rRNA gene sequences
sharing ≥99% sequence similarity were grouped into
arbitrary taxonomic units (ATUs; Fig. 1). For phylogenetic
analysis, only one representative sequence of each ATU
was used. Sequence similarity values were determined
using the “BLAST 2 SEQUENCES” tool of the NCBI
database (http://www.ncbi.nlm.nih.gov/BLAST/bl2seq/
wblast2.cgi; Tatusova and Madden 1999). Isolates with
sequence similarities <97.2% to the next validly described
type strain are assumed to be representatives of potentially
novel species.
Results
Phylogenetic Analysis of Antibiotic-Producing Isolates In
total, 210 isolates were obtained and tested for antibiotic
activity. For all 103 biologically active bacteria isolated,
16S rDNA sequences were obtained. Phylogenetic analysis
according to the sequence data demonstrated that the
bacteria isolated from L. saccharina were affiliated to six
major groups of the bacterial domain, the Gram-positive
Actinobacteria (high G + C) and Firmicutes (low G + C),
the Gram-negative Alphaproteobacteria, Betaproteobacte-
ria, and Gammaproteobacteria, and the Bacteroidetes. The
isolates were assigned to 45 ATUs of >99% sequence
similarity belonging to 21 different genera. For the
calculation of phylogenetic trees, only one representative
of each ATU was used (Fig. 1, Table 1).
Representatives of the Proteobacteria were most
abundant (45 isolates), the majority of which were
affiliated with the γ-subgroup (40 isolates). Two ATUs
belong to the genus Pseudoalteromonas, one of which was
related to Pseudoalteromonas tunicata (ATU PA2 with
three isolates and L28 as representative). This isolate L28
shared 97.5% sequence similarity to the most closely
related type strain, P. tunicata D2T (GenBank EMBL
DNA Databank of Japan (DDBJ) accession no. Z25522).
Isolate LD86 is proposed to represent a novel species of
the family Alteromonadaceae because the 16S rRNA gene
sequence similarity to the most closely related validly
described type strains, Glaciecola mesophila KMM 241T
and Glaciecola polaris LMG 21857T (GenBank EMBL
DDBJ accession nos. AJ488501 and AJ293820), was
96.3%.
Among four isolates affiliated to the Alphaproteobac-
teria, two may represent new species. The comparison of
the 16S rRNA gene sequence of strain L96 with validly
described type strains revealed an identity of 96.8% to
Mesorhizobium chacoense PR5T (GenBank EMBL DDBJ
accession no. AJ278249), which suggests that it may
represent a new Mesorhizobium species. The affiliation of
strain LD81 to a novel genus or even family of the
Alphaproteobacteria related to Rhodospirillales is sup-
ported by a low 16S rRNA gene sequence similarity values
to various validly described type strain of Alphaproteo-
bacteria (90.7% to the most closely related type, which
is Pseudovibrio denitrificans DN34T, GenBank EMBL
DDBJ accession no. AY486423). The highest sequence
similarity (96%) was found, however, to Kopriimonas
byunsanensis, a proposed new species so far not validly
described.
Betaproteobacteria are rarely found in association with
Laminaria. Just a single isolate (LD114) was obtained with
Alcaligenes faecalis as the next relative.
Two representatives of the Bacteroidetes were isolated.
One (LD83) was identified as Olleya marilimosa; the
second (LD84) was related to the genus Cellulophaga and
shared 97.1% sequence similarity with the closest type
strain, Cellulophaga baltica NN015840T (GenBank EMBL
DDBJ accession no. AJ005972) and possibly represents a
new species.
Among the Actinobacteria, most of the isolates were
identified as Streptomyces species (Table 1) and all of the
Firmicutes belong to the genus Bacillus, of which (one L91)
shares 97.5% sequence similarity with its closest described
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Fig. 1 Phylogenetic trees of
Laminaria saccharina-associated
antimicrobially active bacterial
strains calculated with the maxi-
mum likelihood method. The
trees include the closest relative
determined by BLAST search
and next type strain relatives to
the isolates as well as represen-
tatives of closely related marine-
derived strains or 16S rDNA
clone sequences. Bootstrap val-
ues are given in percent (only
numbers above 50 are shown).
Numbers in square brackets give
the number of represented
sequences
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Laminaria isolate LD156 [4] – V 1 
Vibrio ordalii, AY530930
Listonella anguillarum, AM235737
100
Laminaria isolate LD159 [1] – V 2
Vibrio aestuarianus ATCC35048T, X74689
100
100
Laminaria isolate LD150b [1] – V 3 
Vibrio gigantis CAM25T, EF094888
Vibrio crassostreae CAIM1405T, EF094887
99
99
Laminaria isolate LD162 [1] – V 4
Vibrio fischeri ET101, AY292923
81
100
Glaciecola polarisT, AJ293820
Glaciecola mesophila KMM241T, AJ488501
Antarctic bacterium R-11381, AJ440975
Laminaria isolate LD086 [1]
92
91
100
100
Arctic seawater bacterium Bsw20359, DQ064614
Pseudoalteromonas sp. SM9913, AY305857
Laminaria isolate L232a [2] – PA 1
Pseudoalteromonas atlantica IAM12927T, X82134
85
Laminaria isolate L28 [3] – PA 2
Pseudoalteromonas sp. UL1, AF172991
Pseudoalteromonas tunicata D2T, Z25522
100
100
100
100
Aeromonas sp. 868E, DQ504429
Laminaria isolate LD151 [1]
Aeromonas molluscorum 848T, AY532690
99
84
100
Laminaria isolate L171a [1] 
Shewanella sp. IRI-160, AY566557
Shewanella affinis KMM3587T, AY351983
87
100
Cobetia marina KMM734, AY628694
Laminaria isolate L222 [1]
100
100
Laminaria isolate LD119 [14] – PM 1 
Pseudomonas fluorescens AE1, EF528260
Pseudomonas sp. NZ101, AY014819
Pseudomonas sp. LB-3, DQ885602
Laminaria isolate LM24 [1] – PM 2 
Pseudomonas sp. Z64-1zhy, AM411070
100
100
Laminaria isolate LD11 [1] – PM 3 
Pseudomonas sp. NZ124, AY014829
100
gamma proteobacterium BT-P-1, AY539822
Laminaria isolate LD126 [1] – PM 4
99
Laminaria isolate LD80 [2] – PM 5
Pseudomonas sp. clone Lupin-1130m-2-MDA-pse3, EF205269
uncultured bacterium clone SX2-25, DQ469215
Pseudomonas anguilliseptica strain BI, AF439803
100
100
Alcaligenes faecalis strain 5659-H, AJ509012
Laminaria isolate LD114 [1]
Achromobacter xylosoxidans strain F, AJ491845
100
Laminaria isolate L167 [5]
Sewage associated Stenotrophomonas maltophilia e-a21, AJ293470
Stenotrophomonas sp. EC-S105, AB200253
100
Hyphomonas oceanitis SCH-89T, AF082797
Laminaria isolate L229 [1]
Dinoflagellate associated bacterium SCRIPPS_739, AF359546
99
Dinoflagellate associated bacterium ATAM407_2031, AF359536
Sulfitobacter sp. DFL-10, AJ534210
Laminaria isolate LD87 [1]
88
100
100
Laminaria isolate L96 [1]
Mesorhizobium chacoense PR5T, AJ27824999
Pseudovibrio denitrificans, AY486423
‘Kopriimonas byunsanensis‘ KOPRI13522, DQ167245
Laminaria isolate LD81 [1]100
Thalassospira lucentensis DSM 14000T, AM294944
100
100
Cellulophaga sp. strain CC12, DQ356487
Laminaria isolate LD84 [1]
Cellulophaga baltica NN015840T, AJ005972
100
Laminaria isolate LD83 [1]
Olleya marilimosa, AY586527
marine psychrophile bacterium strain SW17, AF001368
85
100
88
100
Bacillus subtilis ATCC6633, DQ207730
0.10
Alpha-PB
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relative, Bacillus patagoniensis PAT 05T (GenBank–EMBL–
DDBJ accession no. AY258614).
Antimicrobial Profiles of the Isolates From a total of 210
bacterial isolates, 103 displayed antimicrobial activity
against at least one of the test strains used in this study
(Tables 2 and 3). The majority of the L. saccharina-
associated isolates were active against the Gram-positive B.
subtilis and S. lentus. Of the isolates, 83.5% showed an
inhibitory effect against B. subtilis and 47.7% against S.
Laminaria isolate L94 [2] – S2
Marine Streptomyces sp. GY-2006, AM421779
Streptomyces fungicidicus YH04, AY636155
Sponge-associated Actinomycetales bacterium NO1, AY944251
Laminaria isolate L105 [5] – S1
Streptomyces flavofungini, EF571003
88
95
96
Sponge-associated Actinomycetales bacterium HPA72, DQ144231
Streptomyces gougerotii NBRC 13043T, AB249982
Laminaria isolat LD101 [4] – S3
Streptomyces intermedius NBRC 13049T, AB184277
96
96
Laminaria isolate L92 [1] – S4
Streptomyces variabilis NRRL B-3984T, DQ442551
Sponge-associated Actinomycetales bacterium C06, AY944259
Streptomyces albogriseolus NRRL B-1305T, AJ494865
93
Laminaria isolate L103 [1] – S10
Streptomyces sp. 3490, EF063500
98
Laminaria isolate L98 [1] – S5
‘Streptomyces maritimus‘ BD26, AF233338
Streptomyces aurantiogriseus NRRL B-5416T, AY999773
81
Laminaria isolate L93 [15] – S6
Streptomyces griseus 52-1, EF571001
Streptomyces sp. YIM8, AF389344
Laminaria isolate L87 [1] – S7
Streptomyces globosus 12620-1, EF371433
82
Streptomyces caviscabies ATCC 51928T, AF112160
Streptomyces flavogriseus DSM 40323T, AJ494864
Laminaria isolate L142 [1] – S9
Streptomyces sp. 98-62, DQ450946
87
Laminaria isolate L155 [1] – S8
Streptomyces sp. KN-1220, AY029699
Streptomyces tauricus, AB045879
100
83
100
95
Amycolatopsis palatopharyngis 1BdzT, AF479268
Laminaria isolate L140 [1]
93
100
Arthrobacter parietis, AJ639830
Laminaria isolate L134 [1] 
Arthrobacter sp. LMG 19501, AJ315069
99
Micrococcus luteus DSM 20030T, AJ536198
Micrococcaceae bacterium KVD-unk-39, DQ490457
Laminaria isolate LD4 [1]
100
100
Laminaria isolate L228 [1]
marine bacterium P_wp0234, AY188942
Leifsonia rubeus, AJ438585
100
90
100
90
97
Bacillus subtilis ATCC6633, DQ207730
Laminaria isolate LD153 [4] – B1
Bacillus axarquiensis CIP108772, DQ993670
Bacillus pumilus CICCHLJ Q74, EF528287
Laminaria isolate LD125 [6] – B2
94
100
Bacillus licheniformis BCRC 12826, EF423608
Laminaria isolate L157 [4] – B3
Bacillus licheniformis MKU8, DQ071568
99
91
Marine Bacillus sp. JL1082, DQ985062
Laminaria isolate L135 [1] – B5
Bacillus aquaemaris TF-12T, AF483625
99
100
Bacillus sp. BM-11_1, AY635875
Laminaria isolate L244 [1] – B4
Bacillus humi LMG22167T, AJ627210
96
100
Bacillus sp. JG-B53, AM293002
Laminaria isolate L89 [1] – B7
Bacillus odysseyi 34hs1T, AF526913
100
97
Bacillus thuringiensis 4Q281, AF155954
Laminaria isolate LD160 [2] – B6
Bacillus cereus strain Delaporte, AF155958100
Bacillus patagoniensis PAT05T, AY258614
Laminaria isolate L91 [1] – B8
Bacillus sp. 17-1, AB043843
81
100
100
100
Escherichia coli strain W3110, AP009048
0.10
Actinobacteria
Firm
icutes
Fig. 1 (continued)
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Table 1 Taxonomic identification and phylogenetic position of the isolate
Genus ATU Number
of
isolates
Representatives Next related strain in tree (similarity) Bacterial
group
Pseudomonas PM1 14 LD119 Pseudomonas sp. LB-3, DQ885602.1 (99.86%) Proteobacteria
PM2 1 LM24 Pseudomonas sp. Z64-1zhy, AM411070 (100%)
PM3 1 LD11 Pseudomonas sp. NZ124, AY014829 (100%)
PM4 1 LD126 Gamma proteobacterium BT-P-1, AY539822 (100%)
PM5 2 LD80 Pseudomonas sp. clone Lupin-1130m-2-MDA-pse3, EF205269
(99.4%)/ Pseudomonas anguilliseptica strain BI, AF439803
(99.4%)
Pseudoalteromonas PA1 2 L232a Arctic seawater bacterium Bsw20359, DQ064614 (99.86%)/
Pseudoalteromonas atlantica IAM12927T, X82134 (99.72%)
PA2 3 L28 Pseudoalteromonas sp. UL1, AF172991 (99.92%)
Stenotrophomonas ST 5 L167 Stenotrophomonas sp. EC-S105, AB200253 (99.86%)
Vibrio V1 4 LD156 Vibrio anguillarum, AM235737 (99.86%)
V2 1 LD159 Vibrio aestuarianus ATCC35048, X74689 (99.57%)
V3 1 LD150b Vibrio gigantis CAM25, EF094888 (99.78%)
V4 1 LD162 Vibrio fischeri ET101, AY292923 (99.86%)
Aeromonas AE 1 LD151 Aeromonas molluscorum 848, AY532690 (99.44%)
Shewanella SH 1 L171a Shewanella sp. IRI-160, AY566557 (99.15%)
Cobetia CO 1 L222 Cobetia marina KMM734, AY628694 (100%)
Glaciecola GL 1 LD86 Antarctic bacterium R-11381, AJ440975 (97.77%)/
Glaciecola mesophila KMM241, AJ488501 (96.57%)
Alcaligenes AL 1 LD114 Alcaligenes faecalis strain 5659-H, AJ509012 (99.93%)
Sulfitobacter SU 1 LD87 Sulfitobacter sp. DFL-10, AJ534210 (99.92%)
Hyphomonas HY 1 L229 Hyphomonas oceanitis SCH-89, AF082797 (99.84%)
Mesorhizobium ME 1 L96 Mesorhizobium chacoense PR5, AJ278249 (96.76%)
Proposed new
genus Kiloniella
KI 1 LD81 Kopriimonas byunsanensis KOPRI13522, DQ167245 (96.57%)
Cellulophaga CE 1 LD84 Cellulophaga sp. strain CC12, DQ356487 (99.33%) Bacteroidetes
Olleya OL 1 LD83 Olleya marilimosa, AY586527 (99.12%)
Streptomyces S1 5 L105 Streptomyces flavofungini, EF571003 (100%) Actinobacteria
S2 2 L94 Marine Streptomyces sp. GY-2006, AM421779 (100%)/
Streptomyces fungicidicus YH04, AY636155 (100%)
S3 4 LD101 Sponge-associated Actinomycetales bacterium HPA72,
DQ144231 (99.92%)/Streptomyces gougerotii NBRC 13043,
AB249982 (99.92%)
S4 1 L92 Sponge-associated Actinomycetales bacterium C06, AY944259
(99.93%)/ Streptomyces variabilis NRRL B-3984T, DQ442551
(99.59%)
S5 1 L98 ‘Streptomyces maritimus’ BD26, AF233338 (99.04%)/
Streptomyces aurantiogriseus NRRL B-5416, AY999773
(99.04%)
S6 15 L93 Streptomyces sp. YIM8, AF389344 (99.92%)/
Streptomyces griseus 52-1, EF571001 (99.85%)
S7 1 L87 Streptomyces globosus 12620-1, EF371433 (99.73%)
S8 1 L155 Streptomyces sp. KN-1220, AY029699 (99.71%)/
Streptomyces tauricus, AB045879 (98.74%)
S9 1 L142 Streptomyces sp. 98-62, DQ450946 (99.56%)/
Streptomyces flavogriseus DSM 40323, AJ494864 (99.12%)
S10 1 L103 Streptomyces sp. 3490, EF063500 (99.79%)/
Streptomyces albogriseolus NRRL B-1305, AJ494865 (98.71%)
Leifsonia LE 1 L228 Marine bacterium P_wp0234, AY188942 (100%)/
Leifsonia rubeus CMS 76r, AJ438585 (97.59%)
Amycolatopsis AM 1 L140 Amycolatopsis palatopharyngis 1Bdz, AF479268 (100%)
Arthrobacter AR 1 L134 Arthrobacter parietis, AJ639830 (99.85%)
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lentus, respectively; 30.1% of the isolates were effective
against B. subtilis only; 4.8% were effective against S.
lentus only and 25.2% inhibited the growth of both B.
subtilis and S. lentus. Inhibition of the Gram-negative E.
coli was observed for 19.4% of the isolates with 4.8%
exclusively inhibiting the growth of E. coli. In total, 25.4%
of the isolates were active against the yeast C. glabrata,
5.8% exclusively. Most strains displayed antimicrobial
activity against either one (45.5%) or two (34%) of the test
strains. Of the isolates, 19.5% were active against three, and
one of the bacteria showed activity against all four test
strains (Table 2).
There was no correlation between distinct ATUs and the
15 activity patterns (Table 3). Inhibition of B. subtilis
exclusively (pattern “a”) as the most common one was
observed for 31 out of 57 isolates belonging to 18 different
ATUs. Out of 64 members of 13 ATUs, 26 represented the
activity pattern “e”, inhibiting the growth of B. subtilis and
S. lentus. Eleven isolates, which inhibited the growth of B.
subtilis, S. lentus, and C. glabrata (pattern “l”), affiliated to
eight ATUs consisting of total 36 strains. Further antibiotic
profiles were observed infrequently (Table 3). The inhibi-
tion of C. glabrata only (pattern “d”) was exhibited by six
strains each representing a single ATU, which were
affiliated to the genera Cellulophaga, Glaciecola, Pseudo-
monas, Streptomyces, and Sulfitobacter. The activity pattern
“b” (active against S. lentus only) and “k” (active against B.
subtilis, S. lentus, and E. coli) were shown for five ATUs
each. Inhibitory effects on the growth of E. coli only
(pattern “c”) were observed for five isolates belonging to
four ATUs. Three members of three ATUs each exhibited
the activity pattern “f” (active against B. subtilis and E.
coli), “g” (active against B. subtilis and C. glabrata), and
“n” (active against S. lentus, E. coli, and C. glabrata),
respectively. The pattern “h,” “i,” “j,” “m,” and “o” were
represented by single strains belonging to different ATUs
(Table 3).
Table 2 Antimicrobial activity profiles of Laminaria saccharina-
associated bacterial isolates (103 strains)
Inhibition of test strains Activity
pattern
Number of
isolates
Percentage
Only B. subtilis a 31 30.1
Only S. lentus b 5 4.8
Only E. coli c 5 4.8
Only C. glabrata d 6 5.8
B. subtilis and S. lentus e 26 25.2
B. subtilis and E. coli f 3 2.9
B. subtilis and C. glabrata g 3 2.9
S. lentus and E. coli h 1 1.0
S. lentus and C. glabrata i 1 1.0
E. coli and C. glabrata j 1 1.0
B. subtilis, S. lentus, and
E. coli
k 5 4.8
B. subtilis, S. lentus, and
C. glabrata
l 11 10.8
B. subtilis, E. coli, and
C. glabrata
m 1 1.0
S. lentus, E. coli, and
C. glabrata
n 3 2.9
B. subtilis, S. lentus,
E. coli, and C. glabrata
o 1 1.0
The proportion of isolates, which inhibited the growth of a single test
strain or a combination of test strains is given as percentages of total
number tested
Table 1 (continued)
Genus ATU Number
of
isolates
Representatives Next related strain in tree (similarity) Bacterial
group
Micrococcus MI 1 LD4 Micrococcaceae bacterium KVD-unk-39, DQ490457 (99.85%)/
Micrococcus luteus DSM 20030, AJ536198 (99.70%)
Bacillus B1 4 LD153 Bacillus subtilis ATCC 6633, DQ207730 (100%) Firmicutes
B2 6 LD125 Bacillus pumilus CICCHLJ Q74, EF528287 (99.93%)
B3 4 L157 Bacillus licheniformis BCRC 12826, EF423608 (99.93%)
B4 1 L244 Bacillus sp. BM-11_1, AY635875 (99.52%)/Bacillus humi
LMG22167, AJ627210 (98.71%)
B5 1 L135 Marine Bacillus sp. JL1082, DQ985062 (99.59%)/Bacillus
aquaemaris TF-12 (), AF483625 (99.51%)
B6 2 LD160 Bacillus cereus strain Delaporte, AF155958 (99.92%)/Bacillus
thuringiensis 4Q281, AF155954 (100%)
B7 1 L89 Bacillus odysseyi 34hs, AF526913 (98.30%)
B8 1 L91 Bacillus sp. 17-1, AB043843 (97.54%)/Bacillus patagoniensis
PAT05, AY258614 (97.45%)
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Table 3 Affiliation of Laminaria saccharina-associated isolates to ATUs, bacterial groups, and activity pattern (a–o), respectively
Isolate ATU Bacterial group Activity pattern Activity against test strains
B. subtilis E. coli S. lentus C. glabrata
L134 Arthrobacter AR Gram-positive, high GC a + − − −
LD82 Bacillus B2 Gram-positive, low GC a + − − −
L164 Bacillus B3 Gram-positive, low GC a + − − −
L166 Bacillus B3 Gram-positive, low GC a + − − −
L244 Bacillus B4 Gram-positive, low GC a + − − −
L135 Bacillus B5 Gram-positive, low GC a + − − −
L91 Bacillus B8 Gram-positive, low GC a + − − −
L222 Cobetia CO Gammaproteobacteria a + − − −
L96 Mesorhizobium ME Alphaproteobacteria a + − − −
L28 Pseudoalteromonas PA2 Gammaproteobacteria a + − − −
L35 Pseudoalteromonas PA2 Gammaproteobacteria a + − − −
LM24 Pseudomonas PM2 Gammaproteobacteria a + − − −
LD11 Pseudomonas PM3 Gammaproteobacteria a + − − −
LD80 Pseudomonas PM5 Gammaproteobacteria a + − − −
L104 Streptomyces S1 Gram-positive, high GC a + − − −
L108 Streptomyces S1 Gram-positive, high GC a + − − −
L97 Streptomyces S3 Gram-positive, high GC a + − − −
L101 Streptomyces S3 Gram-positive, high GC a + − − −
L107 Streptomyces S3 Gram-positive, high GC a + − − −
L98 Streptomyces S5 Gram-positive, high GC a + − − −
L99 Streptomyces S6 Gram-positive, high GC a + − − −
L100 Streptomyces S6 Gram-positive, high GC a + − − −
L102 Streptomyces S6 Gram-positive, high GC a + − − −
L131 Streptomyces S6 Gram-positive, high GC a + − − −
L132 Streptomyces S6 Gram-positive, high GC a + − − −
L136 Streptomyces S6 Gram-positive, high GC a + − − −
L137 Streptomyces S6 Gram-positive, high GC a + − − −
L138 Streptomyces S6 Gram-positive, high GC a + − − −
L139 Streptomyces S6 Gram-positive, high GC a + − − −
L165 Stenotrophomonas ST Gammaproteobacteria a + − − −
LD7a Vibrio V1 Gammaproteobacteria a + − − −
LD152 Bacillus B1 Gram-positive, low GC b − − + −
L240 Bacillus B3 Gram-positive, low GC b − − + −
L110 Bacillus B6 Gram-positive, low GC b − − + −
LD83 Olleya OL Bacteroidetes b − − + −
L87 Streptomyces S7 Gram-positive, high GC b − − + −
L232 Pseudoalteromonas PA1 Gammaproteobacteria c − + − −
LD126 Pseudomonas PM4 Gammaproteobacteria c − + − −
LD17 Vibrio V1 Gammaproteobacteria c − + − −
LD18 Vibrio V1 Gammaproteobacteria c − + − −
LD162 Vibrio V4 Gammaproteobacteria c − + − −
LD84 Cellulophaga CE Bacteroidetes d − − − +
LD86 Glaciecola GL Gammaproteobacteria d − − − +
LD119 Pseudomonas PM1 Gammaproteobacteria d − − − +
L76 Streptomyces S2 Gram-positive, high GC d − − − +
L77 Streptomyces S6 Gram-positive, high GC d − − − +
LD87 Sulfitobacter SU Alphaproteobacteria d − − − +
LD151 Aeromonas AE Gammaproteobacteria e + − + −
LD153 Bacillus B1 Gram-positive, low GC e + − + −
LD125 Bacillus B2 Gram-positive, low GC e + − + −
LD4 Micrococcus MI Gram-positive, high GC e + − + −
L145 Pseudoalteromonas PA2 Gammaproteobacteria e + − + −
LD45 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD46 Pseudomonas PM1 Gammaproteobacteria e + − + −
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Table 3 (continued)
Isolate ATU Bacterial group Activity pattern Activity against test strains
B. subtilis E. coli S. lentus C. glabrata
LD47 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD49 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD51 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD52 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD53 Pseudomonas PM1 Gammaproteobacteria e + − + −
LM59 Pseudomonas PM1 Gammaproteobacteria e + − + −
LM62 Pseudomonas PM1 Gammaproteobacteria e + − + −
LD118 Pseudomonas PM1 Gammaproteobacteria e + − + −
L112 Streptomyces S1 Gram-positive, high GC e + − + −
L148 Streptomyces S1 Gram-positive, high GC e + − + −
L95 Streptomyces S3 Gram-positive, high GC e + − + −
LM78a Streptomyces S6 Gram-positive, high GC e + − + −
L111 Streptomyces S6 Gram-positive, high GC e + − + −
L130 Streptomyces S6 Gram-positive, high GC e + − + −
L133 Streptomyces S6 Gram-positive, high GC e + − + −
L155 Streptomyces S8 Gram-positive, high GC e + − + −
L142 Streptomyces S9 Gram-positive, high GC e + − + −
L167 Stenotrophomonas ST Gammaproteobacteria e + − + −
LD156 Vibrio V1 Gammaproteobacteria e + − + −
LD12 Pseudomonas PM5 Gammaproteobacteria f + + − −
L94 Streptomyces S2 Gram-positive, high GC f + + − −
L93 Streptomyces S6 Gram-positive, high GC f + + − −
LD81 ‘Kiloniella’ KI Alphaproteobacteria g + − − +
LD114 Alcaligenes AL Betaproteobacteria g + − − +
L105 Streptomyces S1 Gram-positive, high GC g + − − +
L158 Stenotrophomonas ST Gammaproteobacteria h − + + −
L74 Bacillus B2 Gram-positive, low GC i − − + +
L171 Shewanella SH Gammaproteobacteria j − + − +
L149 Bacillus B2 Gram-positive, low GC k + + + −
LD160 Bacillus B6 Gram-positive, low GC k + + + −
L92 Streptomyces S4 Gram-positive, high GC k + + + −
LD159 Vibrio V2 Gammaproteobacteria k + + + −
LD150b Vibrio V3 Gammaproteobacteria k + + + −
L140 Amycolatopsis AM Gram-positive, high GC l + − + +
LD116 Bacillus B1 Gram-positive, low GC l + − + +
LD154 Bacillus B1 Gram-positive, low GC l + − + +
LD121 Bacillus B2 Gram-positive, low GC l + − + +
LD117 Bacillus B2 Gram-positive, low GC l + − + +
L157 Bacillus B3 Gram-positive, low GC l + − + +
L89 Bacillus B7 Gram-positive, low GC l + − + +
LM63 Pseudomonas PM1 Gammaproteobacteria l + − + +
LD120 Pseudomonas PM1 Gammaproteobacteria l + − + +
L103 Streptomyces S10 Gram-positive, high GC l + − + +
L127 Stenotrophomonas ST Gammaproteobacteria l + − + +
L169 Stenotrophomonas ST Gammaproteobacteria m + + − +
L228 Leifsonia LE Gram-positive, high GC n − + + +
L229 Hyphomonas HY Alphaproteobacteria n − + + +
L230 Pseudoalteromonas PA1 Gammaproteobacteria n − + + +
LD115 Pseudomonas PM1 Gammaproteobacteria o + + + +
Different ATUs within the genera Bacillus, Pseudoalteromonas, Pseudomonas, Streptomyces, and Vibrio were numbered
+ antibiotic activity, − no antibiotic activity
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Discussion
L. saccharina occurs mainly in cold to temperate waters of
the Baltic Sea, North Sea, and the North Pacific as well as
the North and South Atlantic (Kain 1979; Lüning 1990).
Studies concerning the bacterial communities associated
with L. saccharina, their ecological role, their interactions
with the algae or other organisms, and their biotechnolog-
ical potential are still limited. It is known from microscopic
and cultivation experiments, which were carried out with
other Laminaria species, that the algae are colonized by
bacteria (Corre and Prieur 1990; Mazure and Field 1980).
Recently, molecular data led to the assumption that there is
a specific association of the bacterial community with
various parts of the algal thallus, i.e., rhizoid, cauloid,
meristem, and phylloid (Staufenberger et al. 2008).
The main topic of this study was the characterization of
the cultured bacterial community of L. saccharina exhibit-
ing antimicrobial activity. In order to determine the
correlation between phylogenetic affiliation of the isolates
and their antibiotic activity, all 103 antibiotically active
strains were grouped into 45 ATUs on the one hand and to
15 different antibiotic patterns on the other hand. Out of 45
ATUs, 31 contained only a single strain and represented
therefore only one antibiotic pattern. The antibiotic profiles
within the remaining 14 of the ATUs were not uniform but
showed up to five different antibiotic patterns each. This
clearly indicates a strain-specific production of biologically
active secondary metabolites. As a consequence, it was not
possible to infer the antibiotic activity from the phyloge-
netic identification of the isolates.
The inhibition of Gram-positive bacteria by the L.
saccharina-associated isolates was more common than the
inhibition of Gram-negative bacteria and yeast. Especially,
the activity against S. lentus led to the assumption that L.
saccharina-associated isolates produce compounds, which
might also inhibit the growth of methicillin-resistant
Staphylococcus aureus (MRSA) strains. These strains are
known to cause severe diseases and belong to the most
common infectious agents in hospitals (Klevens et al.
2006). Furthermore, a proportion of isolates might be able
to produce secondary metabolites against human pathogen-
ic E. coli strains and/or against members of clinically
relevant Candida species, like Candida albicans. Organic
extracts of 16 antibiotic-producing isolates were tested
against human pathogens and revealed that 11 isolates
inhibited the growth of MRSA, E. coli, or C. albicans (data
not shown). Potentially new antibiotic substances active
against these pathogenic strains thus display high clinical
importance and biotechnological potential.
The phylogenetic analysis revealed the affiliation of
antimicrobially active isolates to a variety of bacterial taxa
including different potentially novel species or even genera.
Representatives of the Gram-positive divisions Firmicutes
and the Actinobacteria as well as members of the Gram-
negative Alphaproteobacteria, Betaproteobacteria, and
Gammaproteobacteria were found associated with the alga.
More than half (54%) of the L. saccharina-associated
isolates belong to the Gram-positive bacterial divisions, to
Actinobacteria and to Firmicutes, which include well-
known producers of antibiotic substances. In particular,
the Actinomycetes are known as important sources for
pharmaceutical drugs. Of the presently known antibiotic-
active compounds, over 8,700 substances, 53% were
isolated from members of the Actinomycetales. Moreover,
approximately 70% of all antibiotics used worldwide as
therapeutic drugs are produced by Actinomycetales (Berdy
2005). Within the Firmicutes, especially strains of the
genus Bacillus, are common producers of antimicrobial
compounds. Approximately 800 metabolites with antibiotic
activity, including the important group of peptide anti-
biotics like bacitracin, gramicidin, and polymyxin B are
produced by Bacillus licheniformis, Bacillus brevis, and
Bacillus polymyxin, respectively (Berdy 2005; Ishihara et
al. 2002; Vandamme and Demain 1976; Crisley 1964).
Within the Actinomycetales, the genus Streptomyces
represents the most frequent producers of antibiotic
agents. Examples are tetracycline (Streptomyces viridifa-
ciens), vancomycin (Streptomyces orientalis), fosfomycin
(Streptomyces fradiae), streptomycin (Streptomyces gri-
seus), and the macrolide erythromycin (Streptomyces
erythreus; Cheng et al. 1999; Zheng et al. 2000; Watve
et al. 2001). Also, representatives of other groups of
Actinobacteria, including the genera Amycolatopsis,
Arthrobacter, and Micrococcus identified in this study,
are known as producers of pharmaceutically important
antibiotics. Two antibiotics in clinical use are produced by
Amycolatopsis species. Vancomycin, a glycopeptide anti-
biotic which is used as a drug of last resort in the treatment
of life-threatening infections by Gram-positive bacteria, is
produced by Amycolatopsis orientalis (Hubbard and
Walsh 2003) and a vancomycin-like antibiotic, balhimy-
cin, is produced by Amycolatopsis mediterranei (Reck-
tenwald et al. 2002). The biological activity of the natural
products of these bacteria is not limited to the inhibition of
other bacteria but also can affect eukaryotic organisms,
such as the human parasite Plasmodium falciparum which
is inhibited by micrococcin produced by Micrococcus
varians (Rogers et al. 1998).
Despite the great variety of known antibiotics, novel
chemical classes, produced by these bacteria (Actinobacteria
and Firmicutes), continue to be discovered. Among the
newly discovered natural products of Streptomyces species,
the lipopeptide daptomycin produced by Streptomyces
roseopurpureus was brought into market in 2003 (Baltz et
al. 2005) and platensimycin produced by Streptomyces
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platensis represents a promising candidate of a new
antibiotic drug (Wang 2006). Other antimicrobial active
substances belonging to new structural classes of antibiotics
include azicemicin A and B as well as epoxyquinomicin A,
B, C, and D, isolated from strains closely related to
Amycolatopsis sulphurea (Tsuchida et al. 1995; Matsumoto
et al. 1997) and a novel quinolone antibiotic, YM-30059,
active against multiple drug-resistant S. aureus and Staph-
ylococcus epidermidis strains, isolated from an Arthro-
bacter species (Kamigiri et al. 1996).
A number of secondary metabolites with antimicro-
bial activity also have been identified in members of
the Proteobacteria and the Bacteroidetes. Within the
Alphaproteobacteria, a major clade of marine bacteria
(Giovannoni and Rappé 2000; Gonzalez and Moran
1997), production of antibiotic substances has been identi-
fied in members of the Roseobacter lineage, Sulfitobacter
pontiacus, Roseovarius sp., and Oceanibulbus indoliflex.
Roseobacter species produce tropodithietic acid, a novel
antibiotic, effective against marine bacteria and algae
(Brinkhoff et al. 2004). Tryptanthrin, first discovered in
1987 as an antimicrobial plant metabolite and later patented
as an antimalaria pharmacophore (Bhattacharjee et al. 2004),
is also produced by the marine alphaproteobacterium O.
indoliflex (Wagner-Döbler et al. 2004). Antibiotic activity
against E. coli, S. aureus, and C. glabrata was found in S.
pontiacus, related to the alga-derived isolate LD87 (Toledo
et al. 2006) and also in Alphaproteobacteria closely related
to P. denitrificans and Ruegeria atlantica, which were
found to dominate the cultured bacteria isolated from
Mediterranean sponges (Muscholl-Silberhorn et al. 2008).
Members of the Betaproteobacteria have been detected
mainly in freshwater habitats but rarely in oceanic
environments (Nold and Zwart 1998). We isolated a
marine alga-associated strain of the betaproteobacterial
genus Alcaligenes (LD114). Other members of this genus,
such as Alcaligenes xylosoxidan, display biotechnological
potential in antifungal biocontrol by inhibition of two
fungal plant pathogens Rhizoctonia bataticola and Fusa-
rium sp. (Vaidya et al. 2001).
Also, representatives of the Gammaproteobacteria,
which have been isolated in this study, species of
Pseudomonas, Pseudoalteromonas, Stenotrophomonas,
Vibrio, Aeromonas, and Shewanella, yielded antimicrobial
substances. From a total of 22,500 biologically active
substances derived from bacteria and fungi, 610 (2.7%) are
produced from Pseudomonas species (Berdy 2005), among
these massetolide A (Gerard et al. 1997). Pseudoalteromo-
nas strains are less frequently reported as producers of
antibiotic substances. Longeon et al. (2004) highlighted a
Pseudoalteromonas isolate as producer of a novel antimi-
crobial protein, which inhibited human pathogenic strains
causing dermatologic diseases. Minkwitz and Berg (2001)
demonstrated antifungal activities of Stenotrophomonas
maltophilia strains against the yeast C. albicans and
phytopathogenic fungi. Vibrio strains are known to produce
antibiotic-active peptides like andrimid (Oclarit et al. 1994),
which represent a new class of antibiotics targeting bacterial
fatty acid biosynthesis (Pohlmann et al. 2005). An Aero-
monas isolate was found to produce a glucosidic cyclic
lactone showing an antifungal activity (Afonso et al. 1999).
Representatives of the Bacteroidetes group from aquatic
habitats are known as surface-associated bacteria, as they
were found predominantly in floating aggregates (Nold and
Zwart 1998). As reviewed by Michel et al. (2006),
Flavobacteria were found to produce carrageenases and
agarase and are hence able to degrade algal compounds.
Thus, the algal isolates affiliated with the Bacteroidetes
possibly represent opportunistic alga-degrading bacteria.
Nevertheless, CFB group members have also been shown
to produce secondary metabolites with biotechnological
potential. Fucoidan hydrolases (Urvantseva et al. 2006) and
other substances with algaecidal properties can be of great
use to prevent shellfish farms from closing due to toxic
dinoflagellate blooms (Skerratt et al. 2002).
In addition to members of known antibiotic-producing
taxa, especially representatives of novel species or genera
isolated from marine habitats may be valuable sources of
novel biologically active metabolites, which have not
been derived from terrestrial environments (Bernan et al.
2004; Fiedler et al. 2005; Jensen et al. 2005; Lam 2006).
As reviewed recently by Bull and Stach (2007), marine
Actinobacteria harbor an unrivaled capacity to produce ex-
ploitable natural products. Especially members of novel ma-
rine genera, such as the recently described genus Salinispora
(Fenical and Jensen 2006), exhibit a high potential to
produce new antibiotics. Salinispora tropica produces the
antitumor agent salinosporamide A, which went into
preclinical trials against cancer (Newman and Cragg 2006).
Not only chemical analysis of culture broth and cell mass
but also genome sequences of marine bacteria provided
valuable information on the potential to produce promising
secondary metabolites (Hopwood 2007; Udwary et al. 2007).
In addition, variation of the cultivation conditions (e.g.,
cultivation on substrate surfaces or in liquid broth, coculti-
vation with other organisms) can influence the production of
secondary metabolites (Yan et al. 2003; Diggle et al. 2007).
Studies on the impact of cultivation conditions for the
production of antimicrobial compounds by the alga-derived
isolates are expected to be a valuable tool in the search for
new antibiotically active substances.
In summary, we have demonstrated that L. saccharina-
associated bacteria have a great potential to produce
antimicrobial compounds. The large variation of antimicro-
bial activity patterns among our isolates (even within single
ATUs), the large number of phylogenetically distinct ATUs,
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and the presence of new species and a new genus among
the isolates are promising results for future work on
antibiotically active compounds produced by these bacteria.
Following studies with these isolates will focus on
functional genetic studies concerning biosynthetic path-
ways of their secondary metabolites and the identification
of chemical structures of the produced substances in order
to unravel their biotechnological potential.
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